Thomas Steyer’s Pfizer PFE Stock Holding History

Thomas Steyer’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000,000	Closed	-$43M	–	312
2021 Q3	$43M	Buy	+1,000,000	New	+$44.3M	0.2%	78

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Thomas Steyer's PFE Position: Q3 2014 in Review

Thomas Steyer sold out of Pfizer (PFE) in Q3 2014, closing a stake of 1,059,270 shares — an estimated $29.8M sold.

Thomas Steyer first reported a position in PFE in Q2 2013 and held it in 2 quarters. The position peaked at $36.3M in Q2 2013. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

Thomas Steyer reported no remaining Pfizer position as of Q3 2014 after selling out during the quarter.
Thomas Steyer sold 1,059,270 Pfizer shares in Q3 2014, an estimated $29.8M.
Thomas Steyer first reported a position in Pfizer in Q2 2013 and held it in 2 quarters.
Thomas Steyer's Pfizer position peaked at $36.3M in Q2 2013.
1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Farallon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.